Extended-spectrum β-lactamases

Seminars in Respiratory Infections

Volumn 15, Issue 4, 2000, Pages 299-307

  Patterson, Jan E ^a,b  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CEPHAMYCIN; COTRIMOXAZOLE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; GRAM NEGATIVE INFECTION; HUMAN; INFECTION CONTROL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

EID: 0034493632     PISSN: 08820546     EISSN: None     Source Type: Journal    
DOI: 10.1053/srin.2000.20934     Document Type: Article

References (62)

1. Escherichia coli and Klebsiella pneumoniae strains more susceptible to cefoxitin than to third-generation cephalosporins
2. Extended broadspectrum beta-lactamases confering transferable resistance to newer beta-lactam agents in Enterobacteriaceae: Hospital prevalence and susceptibility pattem
3. Broad-spectrum, transmissible beta-lactamases
4. Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae
5. Survey of bloodstream infections due to gram-negative bacilli: Frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States
6. Klebsiella pneumoniae bacteremia: Impact of extended-spectrum beta-lactamase production in a global study of 216 patients
7. Origin and impact of plasmid-mediated extended-spectrum beta-lactamases
8. Extended-spectrum beta lactamases
9. More extended-spectrum beta-lactamases
10. Evolution and dissemination of beta-lactamases accelerated by generations of beta-lactam antibiotics
11. Development of resistance in gram-negative pathogens. Extended-spectrum beta-lactamases, in Moellering RC, Jr (ed): Emerging Pathogens in Infectious Disease
12. Amino acid sequences for TEM, SHV and OXA extended-spectrum and inhibitor resistant beta-lactamases
13. Extended-spectrum beta-lactamases and other enzymes providing resistance to oxyimino-beta-lactams
14. Bacterial resistance to antimicrobial agents in Latin America
15. Detection of Klebsiella pneumoniae and Escherichia coli strains produced extended-spectrum beta-lactamases
16. Detection of extended-spectrum beta-lactamase-producing members of the family Enterobacteriaceae with the VITEK ESBL test
17. Detection of extended spectrum betalactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli
18. Antimicrobial resistance in intensive care units
19. Outbreak of multiply resistant Enterobacteriaceae in an intensive care unit: Epidemiology and risk factors for acquisition
20. A case-control study of an outbreak of infections caused by Klebsiella pneumoniae strains producing CTX-I (TEM 3) beta-lactamase
21. Ceftazidime-resistant Klebsiella pneumoniae and Escherchia coli bloodstream infection: A case-control and molecular epidemiologic investigation
22. Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum beta-lactamases
23. Spread of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae: Are beta-lactamase inhibitors of therapeutic value?
24. Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility
25. Prevalence of important pathogens and the antimicrobial activity of parenteral drugs at numerous medical centers in the United States. 11. Study of the intra- and interlaboratory dissemination of extended-spectrum beta-lactamase-producing Enterobacteriaceae
26. Study of an outbreak of cefoxitin-resistant Klebsiella pneumoniae in a general hospital
27. Plasmid-mediated ampC-type beta-lactamase isolated from Klebsiella pneumoniae confers resistance to broad-spectrum beta-lactams, including moxalactam
28. In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum cephalosporins
29. Quinolone resistance from a transferable plasmid
30. In vitro activities of various beta-lactam antimicrobiol agents against clinical isolates of Escherichia coli and Klebsiella spp. resistant to oxyimino cephalosporins
31. Molecular genetics of resistance to both ceftazidime and beta-lactam-beta-lactamase inhibitor combinations in Klebsiella pneumoniae and in vivo response to beta-lactam therapy
32. Efficacies of piperacillin-tazobactam and cefepime in rats with experimental intra-abdominal abscesses due to an extended-spectrum beta-lactamase producing strain of Klebsiella pneumoniae
33. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins
34. Outbreak of ceftazidime resistance due to a novel extended-spectrum betalactamase in isolates from cancer patients
35. Treatment failure due to extended-spectrum beta-lactamase
36. Production of a plasmid-mediated AmpC-like beta-lactamase by a Klebsiella pneumoniae septicaemia isotate
37. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the loss of an outer membrane protein
38. In vivo selection a cephamycin-resistant, porin-deficient mutant of Klebsiella pneumoniae producing a TEM 3 beta-lactamase
39. Bactericidal effect of beta-lactams and amikacin alone or in association against Klebsiella pneumoniae producing extended-spectrum beta-lactamase
40. Carbapenems. Special properties contributing to their activity
41. Molecular epidemiology of plasmid spread among extended broad spectrum beta-lactamase-producing Klebsiella pneumoniae isolates in a pediatric hospital
42. Molecular epidemiology of Klebsiella pneumoniae producing SHV-5 beta-lactamase: Parallel outbreaks due to multiple plasmid transfer
43. Comparison of pulsed-field gel elentrophoresis and randomly amplified DNA polymorphism analysis for typing extended-spectrum beta-lactamase-producing Klebsiella pneumoniae
44. Detection of SHV-5 extended-spectrum beta-lactamase in Klebsiella pneumoniae strains isolated in Italy
45. Epidemiological typing of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates responsible for five outbreaks in a university hospital
46. Epidemiological study by pulsed field gel electrophoresis of an outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumonia in a geriatric hospital
47. Spread of Klebsiella pneumoniae producing SHV-5 beta-lactamase among hospitalized patients
48. Clonal outbreaks of extended-spectrum beta-lactamase-producing strains of Klebsiella pneumoniae demonstrated by antibiotic susceptibility testing, beta-lactamase typing, and multilocus enzyme electrophoresis
49. Hospital outbreak of Klebsiella pneumoniae resistant to broad-spectrum cepbalosporins and beta-lactam-beta-lactamase inhibitor combinations by hyperproduction of SHV-5 beta-lactamase
50. Evidence of interhospital transmission of extended-spectrum beta-lactam resistant Klebsiella pneumoniae in the United States. 1986 to 1993
51. Molecular epidemiology of Klebsiella pneumoniae strains that produce SHV-4 beta-lactamase and which were isolated in 14 French hospitals
52. Guidelines for isolation precautions in hospitals
53. Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center
54. Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: Identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing beta-lactamases in a single isolate
55. Transferable enzymatic resistance to third generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae
56. Association of antibiotic utilization measures and control of multiple drug resistance in extended-spectrum beta-lactamase-producing (ESBL) Klebsiella pneumoniae
57. Effect of a multidisciplinary team on antimicrobial resistance
58. Class restriction of cephatosporin use to control total cephatosporin resistance in nosocomial Klebsiella
59. Clinical and bacteriologic epidemiology of extended-spectrum beta-lactamase-producing strains of Klebsiella pneumoniae in a medical intensive care unit
60. Identification of TEM-26 beta-lactamase responsible for a major outbreak of ceftazidime-resistant Klebsiella pneumoniae